<DOC>
	<DOCNO>NCT00147056</DOCNO>
	<brief_summary>The purpose study evaluate safety MRI-guided focus ultrasound thermal ablation brain tumor perform intact human skull use ExAblate transcranial system . We collect data establish basic safety type treatment basis later study evaluate clinical efficacy .</brief_summary>
	<brief_title>MRI-Guided Focused Ultrasound Feasibility Study Brain Tumors</brief_title>
	<detailed_description>In non-randomized feasibility study , FUS MRI-guidance thermometry give intact human skull brain tumor ten ( 10 ) subject . These subject follow 3-month period contrast MRI clinical exam . The objective : 1 . To evaluate safety ExAblate TcMRgFUS treatment deliver intact human skull brain , treatment , follow-up period 3 month . 2 . To evaluate effect thermal ablation target tumor contrast MR image identify viable tumor , non-viable thermally ablated tissue .</detailed_description>
	<mesh_term>Brain Neoplasms</mesh_term>
	<criteria>1 . Men woman . 2 . Age 18 70 year , inclusive . 3 . Able willing give inform consent . 4 . Subjects ( newly diagnose recurrent ) metastatic cancer surgery , radiation , radiosurgery advise treat physician . 5 . The targeted tumor tissue locate cerebral hemisphere , &gt; 2.5 cm inner table skull . Nontargeted part tumor may extend outside treated tumor limit . 6 . Tumor ( ) clearly define pretherapy contrast enhance MRI scan . 7 . Size targeted portion tumor ( i.e . prescribed Region Of Treatment ) less 2.5 cm diameter 8 cm3 volume . The nontargeted tumor tissue may exceed targeted volume . 8 . Karnofsky rating 70100 ( See Appendix A ) . 9 . ASA score 12 . 10 . Able communicate sensation ExAblate MRGFUS procedure . 11 . Able attend study visit ( i.e . life expectancy least 3 month ) . 12 . At least 14 day pass since last brain surgery , intracranial radiation therapy/radiosurgery 1 . The subject present : Symptoms sign increase intracranial pressure ( e.g. , headache , nausea , vomit , lethargy , papaedema ) . Unstable hemodynamic status include : i. Documented myocardial infarction within six month enrollment . ii.Symptomatic coronary artery stenosis . iii . Congestive heart disease require medication . iv . Antiarrhythmic drug medication . v. Cardiac pacemaker . vi . Severe hypertension ( diastolic BP &gt; 100 medication ) . 2 . Anticoagulant therapy , medication know increase risk hemorrhage , ( e.g . : nonsteroidal antiinflammatory drug ( NSAIDs ) , statins 3 . TIA stroke last 1 month 4 . Insulindependent diabetes mellitus 5 . Immunosuppression ( corticosteroids prevent brain edema permit ) 6 . Known sensitivity gadoliniumDTPA 7 . Contraindications MRI nonMRIcompatible implant device 8 . Large subject fit comfortably MRI scanner 9 . Difficulty lay supine still 4 hour MRI unit claustrophobia 10 . Untreated , uncontrolled Sleep apnea 11 . Positive pregnancy test ( premenopausal woman ) 12 . Known lifethreatening systemic disease 13 . More 3 metastatic tumor 14 . History abnormal bleeding coagulopathy 15 . Use Avastin precede two week plan use forthcoming two week VEGF inhibitor within + 30 day treatment 16 . Patients history uncontrolled seizure anti seizure medication ( e.g. , Phenytoin 100 mg PO t.i.d . Keppra 500 mg po bid ) procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Brain tumor</keyword>
	<keyword>Brain Lesions</keyword>
	<keyword>Brain Cancer</keyword>
	<keyword>ExAblate</keyword>
</DOC>